Peptides DB
Research-centric peptide and protocol reference hub

Cerebrolysin vs Semax

Updated September 21, 2026 · Reviewed by the PeptidesDB Editorial team

Cerebrolysin: Research use — not FDA-approvedSemax: Research use — not FDA-approved

A data-driven comparison of Cerebrolysin and Semax (also searched as Semax vs Cerebrolysin) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

Cerebrolysin centers on neuro, while Semax leans toward neuro. On indexed research, Cerebrolysin is ahead (Cerebrolysin: 20 studies, Human clinical; Semax: 13, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • Cerebrolysin is strongest for neuro; Semax for neuro.
  • Evidence: Cerebrolysin Human clinical (20 studies) vs Semax Human clinical (13).
  • Both are research-use compounds — not FDA-approved.

Effect profiles, overlaid

CerebrolysinSemax

At a glance

CerebrolysinHuman clinical

Neuroprotective | Stroke recovery and dementia

Strongest: NeuroStudies: 20Level: Well Studied
SemaxHuman clinical

Synthetic ACTH Analog | Nootropic & Neuroprotective Peptide

Strongest: NeuroStudies: 13Level: Well Studied

Cerebrolysin vs Semax: side-by-side

MetricCerebrolysinSemax
ClassNeuroCognitive
Regulatory statusResearch use onlyResearch use only
Evidence gradeHuman clinicalHuman clinical
Studies indexed2013
Research levelWell StudiedWell Studied
Strongest effectNeuro & moodNeuro & mood
Healing & recovery3.02.0
Muscle & body comp0.00.0
Metabolic & appetite0.00.0
Neuro & mood5.04.0
Sleep & circadian0.00.0
Inflammation & immune2.03.0
Skin & aesthetics0.00.0

▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).

Mechanism & pharmacokinetics

PropertyCerebrolysinSemax
MechanismNeurotrophic and neuroprotective effectsACTH(4–10) analog; neuroprotective / nootropic
RouteIntravenous or intramuscular injectionIntranasal (research use)

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is Cerebrolysin?

Cerebrolysin is a porcine brain-derived peptide preparation studied for stroke recovery, dementia, and TBI, with proposed neurotrophic and neuroprotective effects on the central nervous system.

Full Cerebrolysin profile, mechanism & studies →

What is Semax?

Semax is a synthetic peptide derived from the adrenocorticotropic hormone (ACTH) that has been investigated for its potential neuroprotective and cognitive-enhancing effects. Research suggests that Semax may influence various biological pathways, including neuroinflammation and intracellular calcium dynamics.

Full Semax profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingCerebrolysin3.0/5 effect signal
NeuroCerebrolysin5.0/5 effect signal
InflammationSemax3.0/5 effect signal

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack Cerebrolysin and Semax?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

Cerebrolysin vs Semax: side effects

Cerebrolysin

No community-reported effects logged yet.

Semax

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

Cerebrolysin has 20 approved studies indexed (Human clinical), and Semax has 13 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is Cerebrolysin or Semax better?

It depends on your goal. Cerebrolysin is strongest for neuro; Semax for neuro. Cerebrolysin has more indexed studies (20). See the goal-by-goal breakdown above.

Which has more research, Cerebrolysin or Semax?

Cerebrolysin has 20 approved studies indexed (Human clinical); Semax has 13 (Human clinical). Higher counts mean more to read, not proven superiority.

Can you stack Cerebrolysin and Semax?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of Cerebrolysin vs Semax?

Cerebrolysin: no community-reported effects logged yet. Semax: none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is Cerebrolysin or Semax FDA-approved?

Cerebrolysin is a research-use compound and is not FDA-approved. Semax is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is Semax better than Cerebrolysin?

For neuro, Semax has the edge; for neuro, Cerebrolysin does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

Cerebrolysin and Semax are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed September 21, 2026.